157
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Obtention and characterization of the recombinant simian Interleukin-15 in Escherichia coli for the preclinical assessment of an IL-15-based therapeutic vaccine

, , , , , & show all

References

  • Burton, J.D.; Bamford, R.N.; Peters, C.; Grant, A.J.; Kurys, G.; Goldman, C.; et al. A Lymphokine, Provisionally Designated Interleukin T and Produced by a Human Adult T-Cell Leukaemia Line, Stimulates T-Cell Proliferation and the Induction of Lymphokine-Activated Killer Cells. Proc. Natl. Acad. Sci. 1994, 91, 4935–4939.
  • Grabstein, K.H.; Eisenman, J.; Shanebeck, K.; Rauch, C.; Srinivasan, S.; Fung, V.; et al. Cloning of a T Cell Growth Factor that Interacts with the Beta Chain of the Interleukin-2 Receptor. Science 1994, 264(5161), 965–968.
  • Giri, J.G.; Ahdieh, M.; Eisenman, J.; Shanebeck, K.; Grabstein, K.; Kumaki, S.; et al. Utilization of the Beta and Gamma Chains of the IL-2 Receptor by the Novel Cytokine IL-15. EMBO J. 1994, 13(12), 2822–2830.
  • Giri, J.G.; Kumaki, S.; Ahdieh, M.; Friend, D.J.; Loomis, A.; Shanebeck, K.; et al. Identification and Cloning of a Novel IL-15 Binding Protein that is Structurally Related to the Alpha Chain of the IL-2 Receptor. EMBO J. 1995, 14(15), 3654–3663.
  • Budagian, V.; Bulanova, E.; Paus, R.; Bulfone-Paus, S. IL-15/IL-15 Receptor Biology: A Guided Tour through an Expanding Universe. Cytokine Growth Factor Rev. 2006, 17(4), 259–280.
  • Tagaya, Y.; Kurys, G.; Thies, T.A.; Losi, J.M.; Azimi, N.; Hanover, J.A.; et al. Generation of Secretable and Nonsecretable Interleukin 15 Isoforms through Alternate Usage of Signal Peptides. Proc. Natl. Acad. Sci. USA. 1997, 94(26), 14444–14449.
  • Meazza, R.; Verdiani, S.; Biassoni, R.; Coppolecchia, M.; Gaggero, A.; Orengo, A.M.; et al. Identification of a Novel Interleukin-15 (IL-15) Transcript Isoform Generated by Alternative Splicing in Human Small Cell Lung Cancer Cell Lines. Oncogene 1996, 12, 2187–2192.
  • Kozak, M. Features in the 5’ Non-coding Sequences of Rabbit Alpha and Beta-Globin mRNAs that Affect Translational Efficiency. J. Mol. Biol. 1994, 235(1), 95–110.
  • Bamford, R.N.; De Filippis, A.P.; Azimi, N.; Kurys, G.; Waldmann, T.A. The 5’Untranslated Region, Signal Peptide, and the Coding Sequence of the Carboxyl Terminus of IL-15 Participate in Its Multifaceted Translational Control. J. Immunol. 1998, 160, 4418–4426.
  • Nishimura, H.; Fujimoto, A.; Tamura, N.; Yajima, T.; Wajjwalku, W.; Yoshikai, Y. A Novel Autoregulatory Mechanism for Transcriptional Activation of the IL-15 Gene by a Nonsecretable Isoform of IL-15 Generated by Alternative Splicing. FASEB J. 2005, 19, 19–28.
  • Burska, A.; Boissinot, M.; Ponchel, F. Cytokines as Biomarkers in Rheumatoid Arthritis. Mediators Inflamm. 2014, 2014, 545493.
  • Villadsen, L.S.; Schuurman, J.; Beurskens, F.; Dam, T.N.; Dagnaes-Hansen, F.; Skov, L.; et al. Resolution of Psoriasis upon Blockade of IL-15 Biological Activity in a Xenograft Mouse Model. J. Clin. Invest. 2003, 112(10), 1571–1580.
  • Yadav, P.K.; Chen, C.; Liu, Z. Potential Role of NK Cells in the Pathogenesis of Inflammatory Bowel Disease. J. Biomed. Biotechnol. 2011, 2011, 348530.
  • Patterson, K.C.; Hogarth, K.; Husain, A.N.; Sperling, A.I.; Niewold, T.B. The Clinical and Immunologic Features of Pulmonary Fibrosis in Sarcoidosis. Transl. Res. 2012, 160(5), 321–331.
  • Lillehoj, H.S.; Min, W.; Choi, K.D.; Babu, U.S.; Burnside, J.; Miyamoto, T.; et al. Molecular, Cellular, and Functional Characterization of Chicken Cytokines Homologous to Mammalian IL-15 and IL-2. Vet. Immunol. Immunopathol. 2001, 82, 229–244.
  • Dean, G.A.; Barger, A.; Lavoy, A. Cloning and Expression of Feline Interleukin 15. Cytokine 2005, 29(2), 77–83.
  • Xiong, C.; Hixson, P.M.; Mendoza, L.H.; Smith, C.W. Cloning and Expression of Rabbit Interleukin-15. Vet. Immunol. Immunopathol. 2005, 107(1–2), 131–141.
  • Kigawa, T.; Yamaguchi-Nunokawa, E.; Kodama, K.; Matsuda, T.; Yabuki, T.; Matsuda, N.; et al. Selenomethionine Incorporation into a Protein by Cell-Free Synthesis. J. Struct. Funct. Genom. 2002, 2(1), 29–35.
  • Santos, A.; Morera, Y.; Araña, M.; Ferrero, J.; Moro, A.; García, J.; et al. Obtaining Biologically Active IL-15 in Escherichia coli. Biotecnol. Apl. 2000, 17(4), 221–224.
  • Ward, A.; Anderson, M.; Craggs, R.I.; Maltby, J.; Grahames, C.; Davies, R.A.; et al. E. coli Expression and Purification of Human and Cynomolgus IL-15. Protein Exp. Purif. 2009, 68, 42–48.
  • Rodríguez-Álvarez, Y.; Morera-Díaz, Y.; Gerónimo-Pérez, H.; Castro-Velazco, J.; Martínez-Castillo, R.; Puente-Pérez, P.; et al. Active Immunization with Human Interleukin-15 Induces Neutralizing Antibodies in Non-human Primates. BMC Immunol. 2016, 17, 30.
  • Eisenman, J.; Ahdieh, M.; Beers, C.; Brasel, K., Kennedy, M.K.; Le, T.; et al. Interleukin-15 Interactions with Interleukin-15 Receptor Complexes: Characterization and Species Specificity. Cytokine 2002, 20(3), 121–129.
  • Novoa, L.I.; Machado, J.A.; Fernandez, J.R.; Benitez, J.V.; Narciandi, R.E.; Rodriguez, J.L.; et al. Method for the Expression of Heterologous Proteins Produced in Fused form in E. coli, Use Thereof, Expression Vectors and Recombinant Strains. European Patent Application. 1994, No. 90202108.8.
  • Hori, T.; Uchiyama, T.; Tsudo, M.; Umadome, H.; Ohno, H.; Fukuhara, S.; et al. Establishment of an Interleukin 2-Dependent Human T Cell Line from a Patient with T Cell Chronic Lymphocytic Leukemia Who Is Not Infected with Human T Cell Leukemia/Lymphoma Virus. Blood 1987, 70(4), 1069–1072.
  • Bradford, M.M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal. Biochem. 1976, 72, 248–254.
  • Laemmli, U. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature 1970, 227, 680–685.
  • Towbin, H.; Staehelin, T.; Gordon, J. Electrophoresis Transfer of Proteins from Polyacrylamide Gels to Nitrocellulose Sheets: Procedure and Some Applications. Proc. Natl. Acad. Sci. USA 1979, 76, 4350–4353.
  • Suzarte, E.; Marcos, E.; Gil, L.; Valdés, I.; Lazo, L.; Ramos, Y.; et al. Generation and Characterization of Potential Dengue Vaccine Candidates based on Domain III of the Envelope Protein and the Capsid Protein of the Four Serotypes of Dengue Virus. Arch. Virol. 2014, 159, 1629–1640.
  • Mossman, T. Rapid Colorimetric Assay for Cellular Growth and Survival Application to Proliferation and Cytotoxicity Assays. J. Immunol. Methods 1983, 65(1–2), 55–63.
  • Rodríguez, Y.; Gerónimo, H.; Garay, H.; Castro, J.; García, G.; Santos, A. Application of a Colorimetric CTLL-2 Cell Proliferation Assay for the Evaluation of IL-15 Antagonists. Biotecnol. Apl. 2014, 31(4), 291–296.
  • Jeong, K.J.; Lee, S.Y. Enhanced Production of Recombinant Proteins in Escherichia coli by Filamentation Suppression. Appl. Environ. Microbiol. 2003, 69, 1295–1298.
  • Tsao, Chen-Yu; Hooshangi, S.; Wu, Hsuan-Chen; Valdes, J.J.; Bentley, W.E. Autonomous Induction of Recombinant Proteins by Minimally Rewiring Native Quorum Sensing Regulon of E. coli. Metab. Eng. 2010, 12, 291–297.
  • Menzella, H.G. Comparison of Two Codon Optimization Strategies to Enhance Recombinant Protein Production in Escherichia coli. Microb. Cell Fact. 2011, 10, 15.
  • Carbonell, X.; Villaverde, A. Protein Aggregated into Bacterial Inclusion Bodies Does Not Result in Protection from Proteolytic Digestion. Biotechnol. Lett. 2002, 24(23), 1939–1944.
  • Rudolph, R.; Lilie, H. In Vitro Folding of Inclusion Body Proteins. FASEB J. 1996, 10(1), 49–56.
  • Singh, S.M.; Panda, A.K. Solubilization and Refolding of Bacterial Inclusion Body Proteins. J. Biosci. Bioeng. 2005, 99(4), 303–310.
  • Granadillo, M.; Batte, A.; Lugo, V.M.; Musacchio, A.; Bequet-Romero, M.; Betancourt, L.; et al. Expression, Purification and Characterization of a Recombinant Fusion Protein based on the Human Papillomavirus-16 E7 Antigen. SpringerPlus 2013, 2, 12.
  • Gil, L.; Cobas, K.; Lazo, L.; Marcos, E.; Hernández, L.; Suzarte, E.; et al. A Tetravalent Formulation based on Recombinant Nucleocapsid-like Particles from Dengue Viruses Induces a Functional Immune Response in Mice and Monkeys. J. Immunol. 2016, 197(9), 3597–3606.
  • Silva, R.; Selman, M.; Guillen, G.; Herrera, L.; Fernandez, J.; Novoa, L.; et al. Nucleotide Sequence Coding for an Outer Membrane Protein from Neisseria Meningitidis and Use of Said Protein in Vaccine Preparations. European Patent Office Publication, 1992, No. 0 474313A2.
  • Morera, Y.; Bequet-Romero, M.; Ayala, M.; Lamdán, H.; Agger, E.M., Andersen, P.; et al. Anti-tumoral Effect of Active Immunotherapy in C57BL/6 Mice using a Recombinant Human VEGF Protein as Antigen and Three Chemically Unrelated Adjuvants. Angiogenesis 2008, 11, 381–393.
  • Makrides, S.C. Strategies for Achieving High-level Expression of Genes in Escherichia coli. Microbiol. Rev. 1996, 60(3), 512–538.
  • Yee, L.; Blanch, H.W. Recombinant Protein Expression in High Cell Density Fed-Batch Cultures of Escherichia coli. Biotechnology (NY) 1992, 10(12), 1550–1556.
  • Kwon, W.S.; Da Silva, N.A.; Kellis, J.T. Jr. Relationship between Thermal Stability, Degradation Rate and Expression Yield of Barnase Variants in the Periplasm of Escherichia coli. Protein Eng. 1996, 9(12), 1197–1202.
  • Rosano, G.L.; Ceccarelli, E.A. Recombinant Protein Expression in Escherichia coli: Advances and Challenges. Front Microbiol. 2014, 5, 172.
  • Yansura, D.G.; Henner, D.J. Use of Escherichia coli trp Promoter for Direct Expression of Proteins. Methods Enzymol. 1990, 185, 54–60.
  • Bass, S.H.; Yansura, D.G. Application of the E. coli trp Promoter. Mol. Biotechnol. 2000, 16(3), 253–260.
  • Moller, J.V.; Maire, M. Detergent Binding as a Measure of Hydrophobic Surface Area of Integral Membrane Proteins. J. Biol. Chem. 1993, 268(25), 18659–18672.
  • Auton, M.; Holthauzen, L.M.; Bolen, D.W. Anatomy of Energetic Changes Accompanying Urea-induced Protein Denaturation. Proc. Natl. Acad. Sci. USA 2007, 104(39), 15317–15322.
  • Lim, W.K.; Rosgen, J.; Englandera, S.W. Urea, But Not Guanidinium, Destabilizes Proteins by Forming Hydrogen Bonds to the Peptide Group. Proc. Natl. Acad. Sci. USA 2009, 106(8), 2595–2600.
  • Vyas, V.V.; Esposito, D.; Sumpter, T.L.; Broadt, T.L.; Hartley, J.; Knapp, G.C. 4th; et al. Clinical Manufacturing of Recombinant Human Interleukin 15. I. Production Cell Line Development and Protein Expression in E. coli with Stop Codon Optimization. Biotechnol. Prog. 2012, 28(2), 497–507.
  • Chertova, E.; Bergamaschi, C.; Chertov, O.; Sowder, R.; Bear, J.; Roser, J.D. Characterization and Favorable In Vivo Properties of Heterodimeric Soluble IL-15 · IL-15Rα Cytokine Compared to IL-15 Monomer. J. Biol. Chem. 2013, 288(25), 18093–18103.
  • Nellis, D.; Michiel, D.; Jiang, M.S.; Esposito, D.; Davis, R.; Jiang, H. Characterization of Recombinant Human IL-15 Deamidation and Its Practical Elimination through Substitution of Asparagine 77. Pharm. Res. 2012, 29, 722–738.
  • Bhat, N.H.; Jain, S.K. Immunogenic Evaluation of a Recombinant 49-Kilodalton Outer Membrane Protein of Salmonella typhi as a Candidate for a Subunit Vaccine Against Typhoid. J. Infect. Dis. Immun. 2010, 2(2), 30–40.
  • Kamionka, M. Engineering of Therapeutic Proteins Production in Escherichia coli. Curr. Pharm. Biotechnol. 2011, 12, 268–274.
  • Stoscheck, C.M. Quantitation of Protein. Methods Enzymol. 1990, 182, 50–68.
  • Mattanovich, D.; Branduardi, P.; Dato, L.; Gasser, B.; Sauer, M.; Porro, D. Recombinant Protein Production in Yeasts. Methods Mol. Biol. 2012, 824, 329–358.
  • Uchiyama, Y.; Yorozu, K.; Hashizume, M.; Moriya, Y.; Mihara, M. Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, Ameliorates Joint Swelling in Established Monkey Collagen-induced Arthritis. Biol. Pharm. Bull. 2008, 31(6), 1159–1163.
  • Horai, N.; Nagaoka, T.; Higuchi, I.; Kasai, H.; Yoshioka, T.; Umekita, Y.; et al. Muscle Wasting Associated with Pathologic Change Is a Risk Factor for the Exacerbation of Joint Swelling in Collagen-induced Arthritis in Cynomolgus Monkeys. BMC Musculoskeletal Disord. 2013, 14, 205.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.